Atrophy clinical trials

Explore recruiting atrophy clinical trials.

Recruiting atrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Atrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative age-Related macular degeneration (TIGER): a phase 3, pan-European, two-group, active-control, observer-masked, superiority, randomised controlled surgical trial.

Germany, Ireland, Poland, Netherlands, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multi-center, Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy

Denmark, Spain, Austria, France, Germany, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label Study of Risdiplam in Infants with Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Longitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD Study)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized active-controlled trial for vulvovaGinal atRophy in breAst Cancer patients on Endocrine therapy (GRACE-trial)

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Effect of treatment of the cholinergic precursor Choline Alfoscerate in mild cognitive dysfunction

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Atrophy trials by city

Atrophy in Toronto Atrophy in Vancouver Atrophy in Montreal Atrophy in Calgary Atrophy in Edmonton Atrophy in Ottawa Atrophy in Winnipeg Atrophy in Quebec City Atrophy in Hamilton Atrophy in Kitchener Atrophy in London Atrophy in Halifax Atrophy in New York Atrophy in Los Angeles Atrophy in Chicago Atrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease